Genpact Limited Financials

Market Capitalization $7.87 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	15.30
Forward PE	13.04
Price to Sales TTM	$1.62
Price to Book MRQ	$3.20
Enterprise to Revenue	1.77
Enterprise to EBITDA	10.54

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	10.88%
Operating Margin	15.12%
Return on Assets TTM	9.38%
Return on Equity TTM	22.21%

Income Statement

Revenue TTM	$4,850,827,776
Revenue per Share TTM	$27.38
Quarterly Revenue Growth	7.40%
Gross Profit TTM	$1,722,582,016
EBITDA	$866,119,000
Net Income to Common TTM	$527,576,000
Diluted EPS TTM	$2.94
Quarterly Earnings Growth YoY	11.90%

Balance Sheet

Total Cash MRQ	$565,334,976
Total Cash per Share MRQ	$3.23
Total Debt MRQ	$
Total Debt to Equity MRQ	58.87
Current Ratio MRQ	2.45
Book Value per Share MRQ	$14.05

Cash Flow

Operating Cash Flow TTM	$681,420,992
Levered Free Cash Flow TTM	$510,291,744

G Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	174,661,943
Float Shares	160,543,401
Avg 10 Volume	2,037,029
Avg 30 Volume	None
Shares Short	5,930,433
Short Ratio	3.78
Short % of Shares	3.87%
% Held by Insiders	0.90%
% Held by Institutions	103.08%

Stock Price Summary

Beta	0.95
Fifty Two Week Low	$30.38
Fifty Two Week High	$56.76
Fifty Two Week Change	32.38%
Day 50 MA	$44.57
Day 200 MA	$45.20

Dividends and Splits

Forward Annual Dividend Rate	$0.68
Forward Annual Dividend Yield	1.48%
Trailing Annual Dividend Rate	$0.63
Trailing Annual Dividend Yield	1.37%
Payout Ratio	21.34%
Dividend Date	2025-06-30
Ex Dividend Date	2025-06-18
Last Split Factor
Last Split Date